BioPharma Credit (BPCP)

64.60p
   
  • Change Today:
    -0.50p
  • 52 Week High: 72.10
  • 52 Week Low: 64.13
  • Currency: UK Pounds
  • Volume: 193,694
  • Beta: 0.01

Dividend Data

  31-Dec-2431-Dec-2331-Dec-2231-Dec-2131-Dec-20
1st Interim1.75¢1.75¢1.75¢1.75¢n/a
2nd Interim1.75¢1.75¢1.75¢1.75¢n/a
3rd Interim1.75¢1.75¢1.75¢n/an/a
4th Interim1.75¢1.75¢1.75¢n/an/a
Total Dividend7.00¢7.00¢7.00¢3.50¢n/a
For more dividend details, click here

Fundamentals

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Turnover 148.63 155.36 212.22 127.63 100.55
Operating Profit/(Loss) 122.27 132.40 176.39 108.73 79.67
Net Interest n/a n/a n/a n/a n/a
Profit Before Tax 122.27 132.40 176.39 108.73 79.67
Profit After Tax 122.27 132.40 176.39 108.73 79.67
Total Dividend Paid n/a n/a n/a n/a n/a
Retained Profit/(Loss) for the Financial Year 122.27 132.40 176.39 108.73 79.67
Earnings per Share - Basic 10.00¢ 10.11¢ 12.93¢ 7.91¢ 5.80¢
Earnings per Share - Diluted 10.00¢ 10.11¢ 12.93¢ 7.91¢ 5.80¢
Earnings per Share - Adjusted 10.00¢ 10.11¢ 12.93¢ 7.91¢ 5.80¢
Dividend per Share 7.00¢ 7.00¢ 7.00¢ 7.00¢ 7.00¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Fixed Assets          
Intangible Assets n/a n/a n/a n/a n/a
Tangible Assets n/a n/a n/a n/a n/a
Fixed Investments 1,162.20 1,201.36 1,223.65 1.27 1,194.83
  1,162.20 1,201.36 1,223.65 1.27 1,194.83
Current Assets          
Stocks n/a n/a n/a n/a n/a
Debtors 31.80 20.32 19.84 0.01 0.21
Cash at Bank & in Hand 5.62 135.05 120.53 0.09 193.27
Other Current Assets n/a n/a n/a n/a n/a
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1,199.62 1,356.73 1,364.02 1.37 1,388.31
           
Liabilities          
Creditors: Amount Due Within 1 Year 17.88 15.87 26.30 0.01 9.39
Net Current Assets 19.53 139.50 1,337.71 0.09 184.08
           
Creditors: Amount Due Over 1 Year n/a n/a n/a n/a n/a
Provisions for Liabilities & Charges n/a n/a n/a n/a n/a
Other Liabilities 0.06 n/a 0.26 n/a n/a
Total Liabilities 17.94 15.87 26.56 0.01 9.39
           
Net Assets 1,181.68 1,340.86 1,337.45 1.36 1,378.92
           
Capital & Reserves          
Called Up Share Capital 13.74 13.74 13.74 0.01 13.74
Share Premium Account 607.12 607.12 607.12 0.61 607.12
Other Reserves 526.68 633.47 672.69 0.72 750.51
Profit & Loss Account 34.14 86.53 43.90 0.02 7.55
Shareholders Funds 1,181.68 1,340.86 1,337.45 1.36 1,378.92
           
Minority Interests n/a n/a n/a n/a n/a
Capital Employed 1,181.68 1,340.86 1,337.45 1.36 1,378.92
Cash Flow 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
Net Cash Flow From Operating Activities 111.91 123.18 184.28 0.10 58.07
Returns On Investment & Servicing of Finance n/a n/a n/a n/a n/a
Taxation Paid n/a n/a n/a n/a n/a
Capital Expenditure 39.07 (1.66) 48.19 (0.09) (47.47)
Acquisitions & Disposals n/a n/a n/a n/a n/a
Equity Dividends Paid n/a n/a (156.54) (0.10) n/a
Management of Liquid Resources n/a n/a n/a n/a n/a
Financing (280.42) (106.99) (50.09) n/a (113.96)
Net Increase/Decrease In Cash (129.43) 14.53 25.85 (0.10) (103.36)
Ratios 31-Dec-24 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20
PE Ratio 9.4 8.9 8.1 12.4 n/a
PEG n/a n/a 0.1 0.3 n/a
EPS Growth -1% -22% 64% 36% -30%
Dividend Yield 7.5% 7.8% 6.7% 7.1% 0.0%
Dividend Cover 1.43 1.44 1.85 1.13 0.83
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cashflow Per Share n/a n/a n/a n/a n/a
Pre-tax Profit per Share n/a n/a n/a n/a n/a
Cash Increase / Decrease per Share n/a n/a n/a n/a n/a
Turnover per Share n/a n/a n/a n/a n/a
Net Asset Value per Share n/a n/a n/a n/a n/a
Operating Margin 82.26% 85.22% 83.12% 85.19% 79.23%
ROCE 10.35% 9.87% 13.19% 7,973.06% 5.78%
Net Gearing 1.04% n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: Forecast figures based on normalised accounts.

 

Top of Page